ArticleBritish journal of cancer2014

Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours.

J Martin-Liberal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.